Yashica K Turner, RN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 2015 Red Oak Rd, Coushatta, LA 71019 Phone: 318-932-4087 Fax: 318-932-5415 |
Sheila M Woodard, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1635 Marvel St, Coushatta, LA 71019 Phone: 318-932-9980 |
Mrs. Deborah Jeanne Dejean-eaton, REGISTERED NURSE Registered Nurse - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 1313 Ringgold Ave., Coushatta, LA 71019 Phone: 318-932-4029 Fax: 318-932-5914 |
News Archive
A research team from several institutions being led by the University of California San Diego has deciphered a key component behind a rising epidemic of pathogens that the World Health Organization (WHO) recently added to its list of critical emerging diseases.
The investigators found that compared to the saline control group, the embryos exposed to ethanol experienced increases in tumor size, tumor blood vessel density, cancer cell infiltration of blood vessels, and VEGF levels.
A Ventura County commission is trying to keep secret the details of a state-ordered investigation into the management and claims procedures of a healthcare plan designed to serve the county's neediest residents. Complaints about alleged late payments and poor management prompted the Department of Health Care Services to request that auditors step in and examine the plan's financial condition and claims practices. Gold Coast Health Plan was launched last year to switch an estimated 110,000 Ventura County Medi-Cal beneficiaries into an HMO-style healthcare plan.
Men who have lost their partner to cancer and who are still single four to five years after their loss run a far greater risk of developing mental illness than those who have managed to find a new partner, reveals a unique study of 691 Swedish widowers carried out at the Sahlgrenska Academy.
CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.
› Verified 3 days ago